Key result
Intracoronary nicorandil before STEMI PCI improves perfusion and reduces arrhythmias but lacks short-term prognostic benefit.
Why the study?
Intracoronary nicorandil prior to balloon dilation may improve myocardial perfusion and reduce reperfusion arrhythmia during PPCI for STEMI, but its effect on short-term prognosis is unclear.
Does intracoronary nicorandil injection prior to balloon dilation improve myocardial perfusion and clinical outcomes in STEMI patients undergoing PPCI?
Does intracoronary nicorandil injection prior to balloon dilation improve myocardial perfusion and clinical outcomes in STEMI patients undergoing PPCI?
Intracoronary nicorandil prior to PPCI in STEMI improves myocardial perfusion and reduces reperfusion arrhythmias without affecting short-term prognosis.
May aid perfusion optimization in STEMI PCI; hypothesis-generating for outcomes and requires randomized confirmation.
Intracoronary administration of nicorandil prior to balloon dilation can significantly improve the myocardial perfusion and reduce the occurrence of reperfusion arrhythmia during PPCI for STEMI, but does not affect the short-term prognosis in STEMI patients.
No takes yet. Share an insight, caveat, or question.
Zq et al. (2017) studied this question. Intracoronary nicorandil before primary PCI for STEMI significantly improves myocardial perfusion and reduces reperfusion arrhythmia, but does not affect short-term prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: